Evidence map›Paper›PMID 28685468›Full record

ArticleAdvances in experimental medicine and biology2017

Tissue-Integrating Oxygen Sensors: Continuous Tracking of Tissue Hypoxia.

Natalie A Wisniewski, Scott P Nichols, Soya J Gamsey, Steve Pullins, Kit Y Au-Yeung, Bruce Klitzman, Kristen L Helton

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04514861 (Effectiveness of Measuring Local Tissue Oxygen in Response to Induced Hemodynamic Changes With the Profusa's Wireless Lumee Oxygen Platform in Patients With Peripheral Artery Disease), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04514861 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

Effectiveness of Measuring Local Tissue Oxygen in Response to Induced Hemodynamic Changes With the Profusa's Wireless Lumee Oxygen Platform in Patients With Peripheral Artery Disease (PAD)

TypeinterventionalSponsorProfusa, Inc.Ran2020 to 2028Enrolled53ConditionsPeripheral Artery DiseaseArmsWireless Lumee Oxygen Platform
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Development of a compact NMR system to measure pOJournal of magnetic resonance (San Diego, Calif. : 1997) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Near-Infrared Optical Nanosensors for Continuous Detection of Glucose.Journal of diabetes science and technology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Natalie A WisniewskiProfusa, Inc., South San Francisco, CA, USA. natwis@alumni.duke.edu.
Scott P NicholsProfusa, Inc., South San Francisco, CA, USA.
Soya J GamseyProfusa, Inc., South San Francisco, CA, USA.
Steve PullinsProfusa, Inc., South San Francisco, CA, USA.
Kit Y Au-YeungProfusa, Inc., South San Francisco, CA, USA.
Bruce KlitzmanPlastic Surgery Lab, Duke University, Durham, NC, USA.
Kristen L HeltonProfusa, Inc., South San Francisco, CA, USA.
Profusa (United States) · USDuke University · US

Funding

Implantable multi-analyte sensors for the continuous monitoring of body chemistriR01EB016414 · NIBIB · PROFUSA, INC. · PI MCSHANE, MIKE, WISNIEWSKI, NATALIE ANN · 2012 to 2015
$4.9M
Long-term Luminescence-based Glucose MonitoringR43DK093139 · NIDDK · PROFUSA, INC. · PI WISNIEWSKI, NATALIE ANN · 2011 to 2013
$1.1M
Biocompatibility_of_Implantable_BiosensorsR43DK091155 · NIDDK · PROFUSA, INC. · PI KLITZMAN, BRUCE M, WISNIEWSKI, NATALIE ANN · 2011 to 2011
$127k
NIBIB NIH HHS R01 EB016414NIDDK NIH HHS R43 DK091155NIDDK NIH HHS R43 DK093139NIH HHS R43DK09115
6 · The paper itself

Abstract

We describe a simple method of tracking oxygen in real-time with injectable, tissue-integrating microsensors. The sensors are small (500 μm × 500 μm × 5 mm), soft, flexible, tissue-like, biocompatible hydrogel s that have been shown to overcome the foreign body response for long-term sensing. The sensors are engineered to change luminescence in the presence of oxygen or other analytes and function for months to years in the body. A single injection followed by non-invasive monitoring with a hand-held or wearable Bluetooth optical reader enables intermittent or continuous measurements. Proof of concept for applications in high altitude, exercise physiology, vascular disease, stroke, tumors, and other disease states have been shown in mouse, rat and porcine models. Over 90 sensors have been studied to date in humans. These novel tissue-integrating sensors yield real-time insights in tissue oxygen fluctuations for research and clinical applications.

Indexed as

Monitoring, PhysiologicAnimalsBiosensing TechniquesForeign-Body ReactionHumansHypoxiaInjectionsMiceOximetryOxygenPolyhydroxyethyl MethacrylateRatsSwineOxygenPolyhydroxyethyl MethacrylateBiosensorFluorescenceHydrogelLuminescenceMetabolism

Identifiers

PMID28685468
PMCPMC5657483
OpenAlexW2726592371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.